Literature DB >> 27566688

Quantifying the associations between antibiotic exposure and resistance - a step towards personalised antibiograms.

L Sanden1, M Paul2, L Leibovici3, S Andreassen4.   

Abstract

Empirical antibiotic treatment is selected to target causative bacteria with antibiotics to which they are not resistant. We analysed the increase in bacterial resistance among individual patients associated with antibiotic exposure in the month prior to infection onset, compared to unexposed patients. From a series of prospective cohort studies in the period 2002-2011 at Beilinson Hospital, Israel, 4232 consecutive patients suspected of infection were included. We analysed resistance to antibiotics in bacterial isolates from patients with clinically significant and microbiologically documented infections, starting antibiotics after obtaining cultures (n = 775). In Gram-negative bacteria, significantly higher rates of resistance was associated with exposure to antibiotics, while no significant associations were found for Gram-positive bacteria. Significant odds ratios (ORs) for increased resistance to classes of antibiotics ranged from 2.1 to 3.3 in Gram-negative bacteria from patients exposed to any antibiotic(s), with quinolones having the highest OR, followed by aminoglycosides, penicillins with β-lactamase inhibitor and cephalosporins. The majority of significant associations also had significant ORs after exposure to another class of antibiotics, indicating a substantial effect of cross-resistance. In conclusion, increased resistance was observed following exposure to antibiotics, both from the same class and from other classes. The results indicate a reason to adjust the expected coverage of empirical antibiotic treatments for patients recently exposed to antibiotics, with some antibiotics being more affected than others.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27566688     DOI: 10.1007/s10096-016-2751-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Surveillance of antimicrobial resistance--what, how and whither?

Authors:  R Bax; R Bywater; G Cornaglia; H Goossens; P Hunter; V Isham; V Jarlier; R Jones; I Phillips; D Sahm; S Senn; M Struelens; D Taylor; A White
Journal:  Clin Microbiol Infect       Date:  2001-06       Impact factor: 8.067

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.

Authors:  Mical Paul; Steen Andreassen; Evelina Tacconelli; Anders D Nielsen; Nadja Almanasreh; Uwe Frank; Roberto Cauda; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2006-09-23       Impact factor: 5.790

4.  The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.

Authors:  Amy L Pakyz
Journal:  Pharmacotherapy       Date:  2007-09       Impact factor: 4.705

Review 5.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

Review 6.  Antibiotic resistance: an ecological imbalance.

Authors:  S B Levy
Journal:  Ciba Found Symp       Date:  1997

Review 7.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

Authors:  Céire Costelloe; Chris Metcalfe; Andrew Lovering; David Mant; Alastair D Hay
Journal:  BMJ       Date:  2010-05-18

8.  Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.

Authors:  L Leibovici; R Berger; T Gruenewald; J Yahav; Y Yehezkelli; G Milo; M Paul; Z Samra; S D Pitlik
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

Review 9.  A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance.

Authors:  Brian G Bell; Francois Schellevis; Ellen Stobberingh; Herman Goossens; Mike Pringle
Journal:  BMC Infect Dis       Date:  2014-01-09       Impact factor: 3.090

  9 in total
  4 in total

1.  Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-contol study.

Authors:  Juri Katchanov; Benno Kreuels; Florian P Maurer; Kai Wöstmann; Johannes Jochum; Christina König; Kariem Seoudy; Holger Rohde; Ansgar W Lohse; Dominic Wichmann; Michael Baehr; Camilla Rothe; Stefan Kluge
Journal:  BMC Infect Dis       Date:  2017-02-08       Impact factor: 3.090

2.  Risk Factors of Multidrug Resistant Pathogens Induced Infection in Severe Acute Pancreatitis.

Authors:  Xina Li; Le Li; Lu Liu; Yingying Hu; Shuang Zhao; Jialiang Sun; Gang Wang; Xin Hai
Journal:  Shock       Date:  2020-03       Impact factor: 3.533

Review 3.  Bystander Selection for Antimicrobial Resistance: Implications for Patient Health.

Authors:  Valerie J Morley; Robert J Woods; Andrew F Read
Journal:  Trends Microbiol       Date:  2019-07-06       Impact factor: 17.079

4.  A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis.

Authors:  Lars Müller; Aditya Srinivasan; Shira R Abeles; Amutha Rajagopal; Francesca J Torriani; Eliah Aronoff-Spencer
Journal:  J Med Internet Res       Date:  2021-12-03       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.